Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study

• Main Authors: Takamasa Ohki (Author), Koki Sato (Author), Mayuko Kondo (Author), Eriko Goto (Author), Takahisa Sato (Author), Yuji Kondo (Author), Masatoshi Akamatsu (Author), Shinpei Sato (Author), Hideo Yoshida (Author), Yukihiro Koike (Author), Shuntaro Obi (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background and Objective Experience of the use of lenvatinib (LEN) in the clinical setting remains limited. We conducted this study to elucidate the factors associated with progression-free survival (PFS) in patients with advanced HCC treated with LEN. Methods In this multicenter retrospect...